Biblio Discovery — Demo Discovery Service

14 results for "Matteo Cereda"

Showing 1–14 · 2.67 seconds · RSS

  1. Journal Article Full text

    Precision Medicine in Osteosarcoma: MATCH Trial and Beyond

    Elisa Tirtei; Anna Campello; Sebastian D. Asaftei et al.

    Cells, Vol. 10 No. 2 · 2021 · English · DOAJ Scopus

    Osteosarcoma (OS) is a rare bone malignant tumour with a poor prognosis in the case of recurrence. So far, there is no agreement on the best systemic therapy for relapsed OS. The availability of next generation sequencing techniques has recently revolutionized clinical research. The sequencing of…

  2. Journal Article

    Optical coherence tomography features of the repair tissue following RPE tear and their correlation with visual outcomes

    Francesco Romano; Salvatore Parrulli; Maurizio Battaglia Parodi et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract To assess the optical coherence tomography (OCT) features of the repair tissue after retinal pigment epithelial (RPE) tear in neovascular age-related macular degeneration. Retrospective, observational study. Medical and imaging records of patients that developed tears after starting…

  3. Journal Article

    Recessive Cancer Genes Engage in Negative Genetic Interactions with Their Functional Paralogs

    Matteo D’Antonio; Rosalinda F. Guerra; Matteo Cereda et al.

    Cell Reports, Vol. 5 No. 6 · 2013 · English · DOAJ Scopus

    Cancer genetic heterogeneity offers a wide repertoire of molecular determinants to be screened as therapeutic targets. Here, we identify potential anticancer targets by exploiting negative genetic interactions between genes with driver loss-of-function mutations (recessive cancer genes) and their…

  4. Journal Article Full text

    HaTSPiL: A modular pipeline for high-throughput sequencing data analysis

    Edoardo Morandi; Matteo Cereda; Danny Incarnato et al.

    PLOS ONE, Vol. 14 No. 10 · 2019 · English · PLOS Scopus

    Background: Next generation sequencing methods are widely adopted for a large amount of scientific purposes, from pure research to health-related studies. The decreasing costs per analysis led to big amounts of generated data and to the subsequent improvement of software for the respective…

    Also available at: DOAJ

  5. Journal Article

    Impaired neutrophil-mediated cell death drives Ewing’s Sarcoma in the background of Down syndrome

    Serena Peirone; Elisa Tirtei; Anna Campello et al.

    Frontiers in Oncology, Vol. 14 · 2024 · English · DOAJ Scopus

    IntroductionEwing Sarcoma (EWS) has been reported in seven children with Down syndrome (DS). To date, a detailed assessment of this solid tumour in DS patients is yet to be made.MethodsHere, we characterise a chemo-resistant mediastinal EWS in a 2-year-old DS child, the youngest ever reported case…

  6. Journal Article

    Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors

    Enrico Berrino; Roberto Filippi; Clara Visintin et al.

    npj Precision Oncology, Vol. 6 No. 1 · 2022 · English · DOAJ Scopus

    Abstract The onset of multiple and metachronous tumors in young patients induces to suspect the presence of genetic variants in genes associated with tumorigenesis. We describe here the unusual case of a 16-year-old patient who developed a synchronous bifocal colorectal adenocarcinoma with distant…

  7. Journal Article

    Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes

    Matteo Cereda; Gennaro Gambardella; Lorena Benedetti et al.

    Nature Communications, Vol. 7 No. 1 · 2016 · English · DOAJ Scopus

    Some individuals present with multiple synchronous colorectal tumours, but the genetic understanding of this is unclear. Here, the authors use a sequencing strategy to show that the synchronous tumours are genetically independent and the patients harbour rare germline damaging mutations in genes…

  8. Journal Article

    Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma

    Thanos P. Mourikis; Lorena Benedetti; Elizabeth Foxall et al.

    Nature Communications, Vol. 10 No. 1 · 2019 · English · DOAJ Scopus

    Identifying driver genes in unstable, heterogenous tumour types can be challenging. Here, Mourikis, Benedetti, Foxall and colleagues present a machine learning algorithm to tackle this problem in esophageal adenocarcinoma.

  9. Journal Article

    Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas

    Enrico Berrino; Laura Annaratone; Sara Erika Bellomo et al.

    Genome Medicine, Vol. 14 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background The “HER2-low” nomenclature identifies breast carcinomas (BCs) displaying a HER2 score of 1+/2+ in immunohistochemistry and lacking ERBB2 amplification. Whether HER2-low BCs (HLBCs) constitute a distinct entity is debated. Methods We performed DNA and RNA high-throughput…

  10. Journal Article

    Huntington’s disease cellular phenotypes are rescued non-cell autonomously by healthy cells in mosaic telencephalic organoids

    Maura Galimberti; Maria R. Nucera; Vittoria D. Bocchi et al.

    Nature Communications, Vol. 15 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Huntington’s disease (HD) causes selective degeneration of striatal and cortical neurons, resulting in cell mosaicism of coexisting still functional and dysfunctional cells. The impact of non-cell autonomous mechanisms between these cellular states is poorly understood. Here we generated…

  11. Journal Article

    A human CAGinSTEM platform for decoding HTT repeats’ somatic instability links CAG interruption to HD pathology in neurons

    Martina Zobel; Gianluca Damaggio; Maria Lidia Mignogna et al.

    Cell Reports, Vol. 44 No. 12 · 2025 · English · DOAJ Scopus

    Summary: Somatic CAG instability in the mutant Huntingtin (HTT) gene is increasingly recognized as a key hallmark of Huntington’s disease (HD). Using our novel human CAGinSTEM platform, we manipulated cis genetic elements influencing instability in human HD neurons, monitoring repeat length…

  12. Journal Article

    RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade

    Marie-Julie Nokin; Alessia Mira; Enrico Patrucco et al.

    Nature Communications, Vol. 15 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Selective KRASG12C inhibitors have been developed to covalently lock the oncogene in the inactive GDP-bound state. Two of these molecules, sotorasib and adagrasib, are approved for the treatment of adult patients with KRASG12C-mutated previously treated advanced non-small cell lung cancer…